Clorox Company risk profile
53 Elevated one input has moved against it
Measured 21 October 2026 from CLX's filed statements. Recomputed nightly.
53 (Elevated), driven by Concentration at 81, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 43 | Elevated | Stable | Drawdown from the 52-week high — 32.7% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 42 | Elevated | Worsening | Cash conversion — 1.04x |
| Leverage and coverage | 57 | Elevated | Worsening | Net debt to EBITDA — 4.60x |
| Competitive position | 54 | Elevated | Stable | Revenue-growth gap against peers — -21.1 percentage points |
| Concentration | 81 | Acute | Stable | Geographic concentration — 7,017 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.